AEROVATE THERAPEUTICS, INC.

Analyst Reco. Aerovate Therapeutics, Inc.

Equities

AVTE

US0080641071

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-17 pm EDT			5-day change	1st Jan Change
20.57 ^USD	-6.12%		+3.73%	-9.10%

May. 13	Aerovate Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 12	Aerovate Therapeutics Insider Sold Shares Worth $334,478, According to a Recent SEC Filing	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Aerovate Therapeutics Insider Sold Shares Worth $334,478, According to a Recent SEC Filing	Apr. 12	MT
Aerovate Therapeutics Insider Sold Shares Worth $300,033, According to a Recent SEC Filing	Apr. 04	MT
Aerovate Therapeutics Insider Sold Shares Worth $908,046, According to a Recent SEC Filing	Mar. 21	MT
Wedbush Adjusts Aerovate Therapeutics Price Target to $48 From $50, Maintains Outperform Rating	23-08-15	MT
Wedbush Lowers Aerovate Therapeutics' Price Target to $50 From $54, Keeps Outperform Rating	23-05-17	MT
Guggenheim Initiates Aerovate Therapeutics at Buy With $36 Price Target	23-03-01	MT
Wedbush Raises Aerovate Therapeutics' PT to $54 From $27 on Increased Confidence in Inhaled TKIs, AV-10; Keeps Outperform Rating	22-12-12	MT
BTIG Upgrades Aerovate Therapeutics to Buy From Neutral, Price Target Is $27	22-12-06	MT
Wedbush Analyst Assumes Coverage on Aerovate Therapeutics at Outperform With $27 Price Target, Down From $32	22-09-19	MT
Wedbush Analyst Assumes Coverage on Aerovate Therapeutics at $27, Down From $32; Outperform Rating Kept	22-09-19	MT
Wedbush Lifts Price Target on Aerovate Therapeutics to $32 From $23, Keeps Outperform Rating	22-08-17	MT
BTIG Downgrades Aerovate Therapeutics to Neutral From Buy	22-08-16	MT
BTIG Initiates Aerovate Therapeutics at Buy With $24 Price Target	22-02-11	MT
AEROVATE THERAPEUTICS : Evercore ISI Group Initiates Aerovate Therapeutics at Outperform Rating With $30 Price Target	21-07-26	MT
AEROVATE THERAPEUTICS : Jefferies Starts Aerovate Therapeutics at Buy With $21 Price Target	21-07-26	MT
AEROVATE THERAPEUTICS : Cowen Initiates Coverage on Aerovate Therapeutics With Outperform Rating	21-07-26	MT
AEROVATE THERAPEUTICS : Wedbush Starts Aerovate Therapeutics at Outperform With $23 Price Target	21-07-26	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

BENEFIT NOW